Adverse events120

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 40 of 120

Type	Event	Organ system	Group	Affected	At risk
other	Urinary tract infection	Infections and infestations	Placebo	3	56
other	Urinary tract infection	Infections and infestations	Nemolizumab (10 mg)	3	55
other	Urinary tract infection	Infections and infestations	Nemolizumab (30 mg)	1	57
other	Urinary tract infection	Infections and infestations	Nemolizumab (90 mg)	1	57
other	Rhinitis	Infections and infestations	Placebo	3	56
other	Rhinitis	Infections and infestations	Nemolizumab (10 mg)	0	55
other	Rhinitis	Infections and infestations	Nemolizumab (30 mg)	3	57
other	Rhinitis	Infections and infestations	Nemolizumab (90 mg)	1	57
other	Folliculitis	Infections and infestations	Placebo	2	56
other	Folliculitis	Infections and infestations	Nemolizumab (10 mg)	0	55
other	Folliculitis	Infections and infestations	Nemolizumab (30 mg)	3	57
other	Folliculitis	Infections and infestations	Nemolizumab (90 mg)	0	57
other	Dermatitis atopic	Skin and subcutaneous tissue disorders	Placebo	18	56
other	Dermatitis atopic	Skin and subcutaneous tissue disorders	Nemolizumab (10 mg)	11	55
other	Dermatitis atopic	Skin and subcutaneous tissue disorders	Nemolizumab (30 mg)	13	57
other	Dermatitis atopic	Skin and subcutaneous tissue disorders	Nemolizumab (90 mg)	16	57
other	Dry skin	Skin and subcutaneous tissue disorders	Placebo	0	56
other	Dry skin	Skin and subcutaneous tissue disorders	Nemolizumab (10 mg)	0	55
other	Dry skin	Skin and subcutaneous tissue disorders	Nemolizumab (30 mg)	3	57
other	Dry skin	Skin and subcutaneous tissue disorders	Nemolizumab (90 mg)	0	57

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03100344/events?page=2